0000000000001019

AUTHOR

Ernesto Valero

showing 56 related works from this author

Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

2017

Abstract Introduction and objectives Heart failure with preserved ejection fraction and reduced ejection fraction share a high mortality risk. However, differences in the rehospitalization burden over time between these 2 entities remains unclear. Methods We prospectively included 2013 consecutive patients discharged for acute heart failure. Of these, 1082 (53.7%) had heart failure with preserved ejection fraction and 931 (46.2%) had heart failure with reduced ejection fraction. Cox and negative binomial regression methods were used to evaluate the risks of death and repeat hospitalizations, respectively. Results At a median follow-up of 2.36 years (interquartile range: 0.96-4.65), 1018 pat…

Malemedicine.medical_specialtyanimal structures030204 cardiovascular system & hematologyPatient Readmission03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineCost of IllnessInterquartile rangeRecurrenceInternal medicinemedicineHumans030212 general & internal medicineAgedHeart FailureEjection fractionbusiness.industryStroke VolumeGeneral Medicinemedicine.diseaseConfidence intervalHospitalizationHeart failureAcute DiseaseCardiologyFemalebusinessHeart failure with preserved ejection fractionRevista espanola de cardiologia (English ed.)
researchProduct

Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes

2015

Abstract Background Frailty predicts mortality after acute coronary syndrome (ACS). The standard frailty scales, such as the Fried score, consist of a variety of questionnaires and physical tests. Our aim was to investigate easily available clinical data and blood markers to predict frailty at discharge, in elderly patients after ACS. Methods A total of 342 patients older than 65 years, survivors after ACS, were included. A high number of clinical variables were collected. In addition, blood markers potentially linked to frailty and related to the processes of inflammation, coagulation, hormonal dysregulation, nutrition, renal dysfunction, and heart dysfunction were determined. Frailty was …

Malemedicine.medical_specialtyAcute coronary syndromeFrail ElderlyMyocardial InfarctionComorbidityDiseaseCohort StudiesRisk FactorsInternal medicineVitamin D and neurologyHumansMedicineMyocardial infarctionAcute Coronary SyndromeCystatin CVitamin DGeriatric AssessmentAgedAged 80 and overbusiness.industryPrognosismedicine.diseaseComorbidityPatient DischargeSurgeryPatient Outcome AssessmentHeart failureHemoglobinometryBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesCohort studyCanadian Journal of Cardiology
researchProduct

Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction.

2013

Abstract Introduction and objectives A variety of cardiac magnetic resonance indexes predict mid-term prognosis in ST-segment elevation myocardial infarction patients. The extent of transmural necrosis permits simple and accurate prediction of systolic recovery. However, its long-term prognostic value beyond a comprehensive clinical and cardiac magnetic resonance evaluation is unknown. We hypothesized that a simple semiquantitative assessment of the extent of transmural necrosis is the best resonance index to predict long-term outcome soon after a first ST-segment elevation myocardial infarction. Methods One week after a first ST-segment elevation myocardial infarction we carried out a comp…

Malemedicine.medical_specialtyNecrosisMagnetic Resonance SpectroscopyMyocardial InfarctionCoronary AngiographyElectrocardiographyNecrosisPredictive Value of TestsInternal medicineEdemamedicineST segmentHumansMyocardial infarctionAgedEjection fractionbusiness.industryHazard ratioGeneral MedicineMiddle Agedmedicine.diseasePrognosisTreatment OutcomeHeart failureCardiologyFemalemedicine.symptombusinessMaceFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction.

2016

Abstract Background Comorbid elderly patients with non-ST-elevation myocardial infarction (non-STEMI) are underrepresented in randomized trials and undergo fewer cardiac catheterizations according to registries. Our aim was to compare the conservative and invasive strategies in these patients. Methods Randomized multicenter study, including 106 patients (January 2012–March 2014) with non-STEMI, over 70 years and with comorbidities defined by at least two of the following: peripheral artery disease, cerebral vascular disease, dementia, chronic pulmonary disease, chronic renal failure or anemia. Patients were randomized to invasive (routine coronary angiogram, n = 52) or conservative (coronar…

Malemedicine.medical_specialtyCardiac Catheterizationmedicine.medical_treatmentComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRevascularizationCoronary Angiography03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesAngioplasty Balloon CoronaryProspective cohort studyNon-ST Elevated Myocardial InfarctionCardiac catheterizationAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelCardiovascular Agentsmedicine.diseaseComorbidityTreatment OutcomeSpainHeart failureCardiovascular agentCardiologyFemalebusinessEuropean journal of internal medicine
researchProduct

Initial experience with the novel BioMime 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions

2017

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyProsthesis Design03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRisk FactorsmedicineHumansProspective Studies030212 general & internal medicineNon-ST Elevated Myocardial InfarctionAgedSirolimusbusiness.industryStentCardiovascular AgentsDrug-Eluting StentsMiddle AgedSurgeryTreatment OutcomeSirolimusFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugEuroIntervention
researchProduct

5877Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome

2019

Abstract Background The Charlson's is the most used comorbidity index. It comprises 19 comorbidities, some of which are infrequent in elderly patients with acute coronary syndrome (ACS), while some others are manifestations of cardiac disease rather than comorbidities. Purpose Our goal was to simplify comorbidity assessment in elderly non-ST-segment elevation ACS patients. Methods The study group consisted of 1 training (n=920, 76±7 years) and 1 testing (n=532; 84±4 years) cohorts. The end-point was all-cause mortality at 1-year follow-up. Comorbidities were assessed selecting those medical disorders other than cardiac disease that were independently associated with mortality by multivariab…

medicine.medical_specialtyAcute coronary syndromebusiness.industryInternal medicineRisk stratificationmedicineCardiology and Cardiovascular Medicinemedicine.diseasebusinessEuropean Heart Journal
researchProduct

Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function

2015

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a renal tubular marker for early renal dysfunction [1]. Recent studies highlighted its role in predicting acute kidney injury (AKI) and clinical outcomes in a wide range of cardiovascular diseases [2], [3], [4] and [5]. However, in heart failure (HF), conflicting results have been reported [4], [5], [6] and [7] and some ambiguities still prevail about the prognostic utility of NGAL beyond standard prognosticators and traditional renal biomarkers. We aimed to evaluate the independent ability of serum NGAL for predicting long-term mortality in patients admitted for acute HF (AHF). We prospectively enrolled 206 patients consecuti…

Malemedicine.medical_specialtyRenal function030204 cardiovascular system & hematologyKidneyKidney Function TestsGastroenterology03 medical and health sciencesNormal renal function0302 clinical medicineText miningLipocalin-2Risk FactorsInternal medicinemedicineHumansIn patient030212 general & internal medicineProspective StudiesMortalityProspective cohort studyAgedAged 80 and overHeart Failurebusiness.industryPlasma neutrophilAcute heart failureMiddle Agedmedicine.diseasePrognosisNeutrophil gelatinase-associated lipocalinHeart failureRenal physiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersRenal function
researchProduct

Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Tr…

2019

Introduction and objectives: Despite the prevalence of heart failure with preserved ejection fraction (HFpEF), there is currently no evidence-based effective therapy for this disease. This study sought to evaluate whether inspiratory muscle training (IMT), functional electrical stimulation (FES), or a combination of both (IMT + FES) improves 12- and 24-week exercise capacity as well as left ventricular diastolic function, biomarker profile, and quality of life in HFpEF. Methods: A total of 61 stable symptomatic patients (New York Heart Association II-III) with HFpEF were randomized (1:1:1:1) to receive a 12-week program of IMT, FES, or IMT + FES vs usual care. The primary endpoint of the st…

MaleQuality of lifemedicine.medical_specialtyAftercareElectric Stimulation Therapy030204 cardiovascular system & hematologyBreathing Exercises03 medical and health sciences0302 clinical medicineOxygen ConsumptionQuality of lifeInternal medicineSurveys and QuestionnairesClinical endpointExercise capacityMedicineFunctional electrical stimulationHumansAerobic capacityAgedHeart FailureExercise Tolerancebusiness.industryInspiratory muscle trainingStroke VolumeGeneral MedicineExercise capacityCombined Modality TherapyTreatment OutcomeHeart failure with preserved ejection fractionEchocardiographySample SizeCardiologyBiomarker (medicine)FemalebusinessHeart failure with preserved ejection fractionPhysical therapy
researchProduct

Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain.

2014

The additional diagnostic and prognostic information provided by delta high-sensitivity troponin T (hs-cTnT) in patients with acute chest pain and hs-cTnT elevation remains unclear.The study group consisted of 601 patients presenting at the emergency department with non-ST-segment elevation acute chest pain and hs-cTnT elevation after two determinations (admission and within the first six hours). Maximum hs-cTnT and delta hs-cTnT (absolute or percentage change between the two measurements) were considered. Cutoff values were optimized using the quartile distribution for the endpoints. The endpoints were diagnostic (significant stenosis in the coronary angiogram) and prognostic (death or rec…

Malemedicine.medical_specialtyChest Pain030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineChest pain03 medical and health sciences0302 clinical medicineTroponin TInternal medicinemedicineST segmentHumans030212 general & internal medicineMyocardial infarctionAgedTroponin TbiologySurrogate endpointbusiness.industryGeneral MedicineEmergency departmentMiddle Agedmedicine.diseasePrognosisTroponinQuartileCardiologybiology.proteinFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean heart journal. Acute cardiovascular care
researchProduct

High-sensitivity troponin T and the risk of recurrent readmissions after hospitalization for acute heart failure

2017

Abstract Objectives High-sensitivity troponin is a biomarker of myocardial damage and is associated with a greater risk of mortality and disease progression in patients with acute heart failure (AHF). However, its relationship with the risk of future readmissions is less known. The aim of this study was to assess the association between ultrasensitive troponin T (TnT-us) values in patients with AHF and the risk of recurrent readmissions in the follow-up. Methods We prospectively included a cohort of 621 consecutive patients with AHF, excluding those patients with acute coronary syndrome. We measured the TnT-us levels obtained during the first medical contact in the emergency department. The…

Acute coronary syndromemedicine.medical_specialtybiologyTroponin Tbusiness.industryGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseRate ratioTroponin03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineHeart failureCohortmedicineRisk of mortalitybiology.proteinCardiology030212 general & internal medicinebusinessRevista Clínica Española (English Edition)
researchProduct

Iron deficiency and risk of early readmission following a hospitalization for acute heart failure

2016

03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industryHeart failureInternal medicinemedicine030212 general & internal medicineIron deficiency030204 cardiovascular system & hematologyCardiology and Cardiovascular Medicinemedicine.diseasebusinessEuropean Journal of Heart Failure
researchProduct

Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure

2020

Background: Plasma amino-terminal pro-B-type natriuretic peptide and antigen carbohydrate 125 levels are positively associated with a higher risk of adverse clinical outcomes in acute heart failure. As a proxy of congestion, antigen carbohydrate 125 has also been proposed as a right-sided heart failure marker. Thus, we aimed to determine in this population the main factors – including echocardiographic right-sided heart failure parameters – associated with antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide. Methods and results: We prospectively included 2949 patients admitted with acute heart failure. Amino-terminal pro-B-type natriuretic peptide and antigen carbohy…

Malemedicine.medical_specialtymedicine.drug_classacute heart failureAmino terminalCa 125 antigen030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineAntigenInternal medicineNatriuretic Peptide BrainNatriuretic peptidemedicineHumans030212 general & internal medicineProspective Studiesright-sided heart failureProtein PrecursorsAgedHeart Failurebusiness.industryGeneral MedicineCarbohydratemedicine.diseasePrognosisPeptide FragmentsEndocrinologyEchocardiographyNT-proBNPHeart failureCA-125 AntigenAcute DiseaseDisease ProgressionFemaleAntigen carbohydrate 125Cardiology and Cardiovascular MedicinebusinessRight-sided heart failureBiomarkersFollow-Up Studies
researchProduct

Papel de la lipocalina asociada a la gelatinasa neutrófila en la detección precoz de la nefropatía inducida por contraste tras una coronariografía

2016

03 medical and health sciences0302 clinical medicinebusiness.industry030232 urology & nephrologyMedicine030204 cardiovascular system & hematologyCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Randomized Comparison of Exercise Intervention Versus Usual Care in Older Adult Patients with Frailty After Acute Myocardial Infarction.

2020

Abstract Background Older adult patients with frailty are rarely involved in rehabilitation programs after myocardial infarction. Our aim was to investigate the benefits of exercise intervention in these patients. Methods A total of 150 survivors after acute myocardial infarction, ≥70 years and with pre-frailty or frailty (Fried scale ≥1 points), were randomized to control (n = 77) or intervention (n = 73) groups. The intervention consisted of a 3-month exercise program, under physiotherapist supervision, followed by an independent home-based program. The main outcome was frailty (Fried scale) at 3 months and 1 year. Secondary endpoints were clinical events (mortality or any readmission) at…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineStatistical significanceInternal medicineIntervention (counseling)medicineHumans030212 general & internal medicineMyocardial infarctionAgedAged 80 and overRehabilitationAdult patientsExercise interventionFrailtybusiness.industryHazard ratioGeneral Medicinemedicine.diseaseConfidence intervalExercise TherapyTreatment OutcomeFemalebusinessThe American journal of medicine
researchProduct

Guideliner use for the percutaneous treatment of right coronary artery arising from the left circumflex (L-type single coronary artery)

2015

medicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionmedicine.diseaseRight coronary arterymedicine.arteryInternal medicineSingle coronary arteryCoronary artery anomalymedicineCardiologyCircumflexCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI

2010

Early stratification of patients according to the risk for developing microvascular obstruction (MVO) after ST-segment elevation myocardial infarction (STEMI) is desirable. We aimed to identify predictors of cardiovascular magnetic resonance (CMR)-derived MVO from clinical+ECG, laboratory and angiographic parameters available on admission.Characteristics available on admission were documented in 97 STEMI patients referred for primary angioplasty. MVO was determined using contrast-enhanced CMR.MVO was present in 44 patients (45%). The C-statistic for predicting MVO was: clinical+ECG (.832), laboratory (.743), and angiographic parameters (.669). Adding laboratory to clinical+ECG information d…

AdultMalemedicine.medical_specialtyMyocardial InfarctionMagnetic Resonance Imaging CineCoronary Artery DiseaseDelayed presentationPatient AdmissionPredictive Value of TestsCoronary CirculationDiabetes mellitusInternal medicineHumansMedicineProspective Studiescardiovascular diseasesMyocardial infarctionProspective cohort studyAgedKillip classmedicine.diagnostic_testbusiness.industryMicrocirculationMagnetic resonance imagingMiddle Agedmedicine.diseaseSurgeryPredictive value of testsCardiologyFemaleMyocardial infarction diagnosisCardiology and Cardiovascular Medicinebusinesshuman activitiesInternational Journal of Cardiology
researchProduct

CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.

2019

In acute heart failure (AHF) with right ventricular dysfunction, the roles of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) are poorly understood, and functional tricuspid regurgitation (TR) severity is thought to indicate a poor prognosis. We examined the prognostic abilities of NT-proBNP and CA125 according to TR status among patients with AHF.TR severity was assessed during index hospitalization (108 ± 24 h after admission) and classified as none/trivial, mild, moderate, or severe. Multivariable Cox regression analysis was performed to assess how pre-discharge CA125 and NT-proBNP were associated with long-term all-cause mortality relative t…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classRegurgitation (circulation)030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseases030212 general & internal medicineAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryMembrane ProteinsStroke VolumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsTricuspid Valve InsufficiencyHeart failureCA-125 AntigenCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicineIndex hospitalizationbusinessBiomarkersInternational journal of cardiology
researchProduct

Lipoprotein(a) and long-term recurrent infarction after an episode of ST-segment elevation acute myocardial infarction

2020

Background In established ischemic heart disease, the relationship between lipoprotein(a) and new cardiovascular events showed contradictory results. Our aim was to assess the relationship between lipoprotein(a) and very long-term recurrent myocardial infarction (MI) after an index episode of ST-segment elevation acute myocardial infarction (STEMI). Methods We included 435 consecutive STEMI patients discharged from October 2000 to June 2003 in a single teaching center. The relationship between lipoprotein(a) at discharge and recurrent MI was evaluated through negative binomial regression and Cox regression analysis. Results The mean age was 65 years (55-74 years), 25.5% were women, 34.7% we…

Malemedicine.medical_specialtymedicine.medical_treatmentInfarction030204 cardiovascular system & hematologyRate ratio03 medical and health sciences0302 clinical medicineRecurrenceInternal medicineFibrinolysismedicineRisk of mortalityHumansST segment030212 general & internal medicineMyocardial infarctionAgedRetrospective Studiesbiologybusiness.industryIncidenceGeneral MedicineLipoprotein(a)Middle Agedmedicine.diseaseConfidence intervalSpainbiology.proteinCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesForecastingLipoprotein(a)Coronary Artery Disease
researchProduct

Frailty Tools for Assessment of Long-term Prognosis After Acute Coronary Syndrome

2020

Objective: To evaluate the 5 components of the Fried frailty phenotype (self-reported unintentional weight loss, physical activity questionnaire, gait speed, grip strength, and self-reported exhaustion) for long-term outcomes in elderly survivors of acute coronary syndrome. Methods: A total of 342 consecutive patients (from October 1, 2010, to February 1, 2012) were included. The 5 components of the Fried score and albumin concentration, as malnutrition index, were assessed before hospital discharge. Patients were followed up until April 2020 (median follow-up, 8.7 years). The end point was postdischarge all-cause mortality. Results: Mean ± SD age was 77±7 years and mean ± SD Fried score wa…

IDI integrated discrimination improvementmedicine.medical_specialtyAcute coronary syndrome030204 cardiovascular system & hematology03 medical and health sciencesGrip strength0302 clinical medicineWeight lossInternal medicinemedicineHospital discharge030212 general & internal medicinecNRI continuous net reclassification improvementlcsh:R5-920business.industryHazard ratiomedicine.diseaseHR hazard ratioFrailty assessmentGait speedGRACE Global Registry of Acute Coronary EventsMalnutritionOriginal Articlemedicine.symptombusinesslcsh:Medicine (General)Mayo Clinic Proceedings: Innovations, Quality & Outcomes
researchProduct

Cell-free DNA and Microvascular Damage in ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

2019

INTRODUCTION AND OBJECTIVES Cell-free DNA (cfDNA) in ST-segment elevation myocardial infarction might originate from hyperactivated leukocytes at the coronary lesion. Our aim was to investigate the relationship between cfDNA and coronary reperfusion. METHODS We studied 116 patients treated with primary angioplasty using thrombus aspiration. Coronary (during aspiration) and peripheral (at the end of the procedure) blood samples were drawn for cfDNA, as well as high-sensitivity troponin T and myeloperoxidase quantification. The primary endpoint was no ST-segment resolution (STR) (≥ 70%) and the secondary endpoint was lack of final Thrombolysis In Myocardial Infarction flow 3 (TIMI 3). RESULTS…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial ReperfusionMyocardial Reperfusion Injury030204 cardiovascular system & hematologyLymphocyte ActivationLesion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionTroponin TInternal medicinemedicineClinical endpointLeukocytesST segmentHumanscardiovascular diseasesMyocardial infarctionProspective StudiesPeroxidaseTroponin Tbusiness.industryPercutaneous coronary interventionGeneral MedicineThrombolysisMiddle Agedmedicine.diseaseTreatment OutcomeMicrovesselsCardiologyST Elevation Myocardial InfarctionFemalemedicine.symptombusinessCell-Free Nucleic AcidsTIMIRevista espanola de cardiologia (English ed.)
researchProduct

Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure

2017

Abstract Pulmonary hypertension (PH) is a strong predictor of mortality in patients with heart failure (HF). However, the relationship between PH, through echocardiographic pulmonary artery pressure (PASP) estimation, and the risk of HF rehospitalizations remains unclear. Methods We prospectively included 2343 consecutive patients discharged for acute heart failure (AHF). PH was estimated by echocardiography through PASP determination during the index admission. Patients were categorized as follows across PASP: non-measurable, normal (≤35mmHg), mild (36–45mmHg), moderate (46–60mmHg), or severe PH (>60mmHg). Negative binomial regression method was used to evaluate the association between PAS…

Malemedicine.medical_specialtyHypertension PulmonaryPulmonary Artery030204 cardiovascular system & hematologyPatient ReadmissionCohort Studies03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicine.arteryHumansMedicineProspective Studies030212 general & internal medicineProspective cohort studyAgedAged 80 and overHeart FailureEjection fractionbusiness.industryMiddle Agedmedicine.diseasePulmonary hypertensionConfidence intervalEchocardiographyHeart failureAcute DiseasePulmonary arteryCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesCohort studyInternational Journal of Cardiology
researchProduct

Efecto de la implantación del cuidado transicional en una unidad de insuficiencia cardiaca tras un ingreso por insuficiencia cardiaca aguda

2020

Resumen Introduccion y objetivos Los expertos recomiendan un seguimiento clinico especifico en los pacientes con insuficiencia cardiaca (IC). El objetivo de este trabajo fue evaluar el efecto de la implantacion de un modelo de cuidado transicional en una unidad de IC (UIC) tras una hospitalizacion por IC sobre el riesgo de muerte e ingresos recurrentes por IC. Metodos Estudio observacional retrospectivo que incluyo a todos los pacientes dados de alta por IC aguda en un hospital terciario en Espana entre 2004 y 2017. Desde el 2010 el seguimiento tras el alta se realizo en una UIC. Se compararon 2 cohortes cronologicas: antes (2004-2009) y despues del inicio de la UIC (2010-2017). Se evaluo e…

Cardiology and Cardiovascular MedicineREC: CardioClinics
researchProduct

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron : The Myocardial- Trial

2020

Background Intravenous ferric carboxymaltose ( FCM ) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The aim of this study was to examine changes in myocardial iron content after FCM administration in patients with heart failure and iron deficiency using cardiac magnetic resonance. Methods and Results Fifty‐three stable heart failure and iron deficiency patients were randomly assigned 1:1 to receive intravenous FCM or placebo in a multicenter, double‐blind study. T2* and T1 mapping cardiac magnetic resonance sequences, noninvasive surrogates of intramyocardial iron, were eval…

MaleCardiac magnetic resonance*ferric carboxymaltoseMagnetic Resonance Imaging (MRI)Myocardial ironAnèmia*heart failure030204 cardiovascular system & hematologyFerric Compounds0302 clinical medicine030212 general & internal medicineOriginal Researchcardiac magnetic resonance ferric carboxymaltose heart failure iron deficiency myocardial ironAnemia Iron-DeficiencyAnemiaIron deficiencyMiddle AgedMyocardial ironMagnetic Resonance Imaging*myocardial ironMagnetic resonanceCardiologyAdministration IntravenousFemaleCardiology and Cardiovascular Medicine*cardiac magnetic resonancemedicine.medical_specialtyNoninvasive imagingCardiomyopathyIronIntravenous ironHeart failureFERRIC CARBOXYMALTOSE03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansMaltoseAgedPharmacologybusiness.industryMyocardiumIron deficiencyRessonància magnèticaMiocardimedicine.diseaseFerric carboxymaltoseTreatmentHeart failureHematinicsbusinessCardiac magnetic resonance*iron deficiencyFerro
researchProduct

P3543Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

2019

Abstract Heart failure with mid-range ejection fraction (HFmrEF) has been recognized as a distinct HF phenotype, but wether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risk over time remains unclear. We therefore sought to characterize the mordibity burden of HFmrEF patients by evaluating the risk of recurrent hospitalizations following an admission for acute HF. Methods We prospectively included 2,961 consecutive patients discharged for acute HF in our institution from 2004 to 2017. Patients were categorized according to their ejection fraction (EF) obtained by an echocardiograph…

medicine.medical_specialtyEjection fractionbusiness.industryHeart failureInternal medicinemedicineCardiologyCardiology and Cardiovascular Medicinemedicine.diseasebusinessPhenotypeEuropean Heart Journal
researchProduct

Prognostic Value of Geriatric Conditions Beyond Age After Acute Coronary Syndrome

2016

The aim of the present study was to investigate the prognostic value of geriatric conditions beyond age after acute coronary syndrome. This was a prospective cohort design including 342 patients (from October 1, 2010, to February 1, 2012) hospitalized for acute coronary syndrome, older than 65 years, in whom 5 geriatric conditions were evaluated at discharge: frailty (Fried and Green scales), comorbidity (Charlson and simple comorbidity indexes), cognitive impairment (Pfeiffer test), physical disability (Barthel index), and instrumental disability (Lawton-Brody scale). The primary end point was all-cause mortality. The median follow-up for the entire population was 4.7 years (range, 3-2178 …

Gerontologymedicine.medical_specialtyAcute coronary syndromePhysical disabilityActivities of daily livingFrail ElderlyMyocardial InfarctionComorbidity030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineActivities of Daily LivingmedicineClinical endpointHumansCognitive DysfunctionDisabled PersonsProspective Studies030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeProspective cohort studyGeriatric AssessmentAgedbusiness.industryHazard ratioAge FactorsGeneral MedicinePrognosismedicine.diseaseComorbiditybusinessMayo Clinic Proceedings
researchProduct

Feasibility of Implanting 50-60 mm-Tapered Drug Eluting Stents in Chronic Total Occlusions.

2018

Abstract Background Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) usually involves multiple overlapping stents implantation to cover long coronary segments. A higher rate of restenosis has been described with stent overlapping. Recently, new long tapered stents emerged as a potential tool for treating long coronary lesions. Feasibility of using these new devices for the CTO PCI has not been described. The aim of this work was to describe our initial experience with 50 and 60 mm-long tapered sirolimus-eluting stents (SES) in CTO PCI. Methods We included 54 consecutive patients who underwent a CTO PCI and in whom an attempt to implant a 50 or 60 mm-long tapered SE…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentTarget vessel030204 cardiovascular system & hematologyProsthesis DesignCoronary Restenosis03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRestenosismedicineHumanscardiovascular diseases030212 general & internal medicineVascular PatencyAgedRetrospective StudiesSirolimusbusiness.industryPercutaneous coronary interventionStentCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgerysurgical procedures operativeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseFeasibility StudiesFemaleImplantCardiology and Cardiovascular MedicinebusinessCardiovascular revascularization medicine : including molecular interventions
researchProduct

ADN libre y daño microvascular en el infarto agudo de miocardio con elevación del segmento ST tratado con intervención coronaria primaria

2019

Resumen Introduccion y objetivos En el infarto agudo de miocardio con elevacion del segmento ST, el ADN libre circulante podria originarse de los leucocitos activados en la lesion coronaria. El objetivo fue investigar la relacion entre el ADN libre y la reperfusion coronaria. Metodos Se incluyo a 116 pacientes, tratados con angioplastia primaria y tromboaspiracion. Se cuantifico el ADN libre coronario (durante la aspiracion) y periferico (al final del procedimiento), asi como la troponina T ultrasensible y la mieloperoxidasa. El objetivo primario fue la no resolucion del segmento ST (RST) (≥ 70%) y el secundario la ausencia de flujo Thrombolysis In Myocardial Infarction 3 (TIMI 3) final. Re…

03 medical and health sciences0302 clinical medicinebusiness.industryMedicine030204 cardiovascular system & hematologyCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design

2017

Abstract Introduction and objectives The optimal treatment of patients with acute heart failure (AHF) and cardiorenal syndrome type 1 (CRS-1) is far from being well-defined. Arterial hypoperfusion in concert with venous congestion plays a crucial role in the pathophysiology of CRS-I. Plasma carbohydrate antigen 125 (CA125) has emerged as a surrogate of fluid overload in AHF. The aim of this study was to evaluate the clinical usefulness of CA125 for tailoring the intensity of diuretic therapy in patients with CRS-1. Methods Multicenter, open-label, parallel clinical trial, in which patients with AHF and serum creatinine ≥ 1.4 mg/dL on admission will be randomized to: a) standard diuretic str…

medicine.medical_specialtymedicine.medical_treatmentWater-Electrolyte ImbalanceRenal functionCardiorenal syndrome030204 cardiovascular system & hematologyPatient Care Planning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFurosemideInternal medicineHumansMedicine030212 general & internal medicineDiureticsIntensive care medicineHeart FailureCreatinineCardio-Renal Syndromebusiness.industryClinical study designChlorthalidoneMembrane ProteinsGeneral Medicinemedicine.diseasePathophysiologyAcetazolamideClinical trialchemistryCA-125 AntigenCreatinineHeart failureAcute DiseaseCardiologyDiureticbusinessRevista Española de Cardiología (English Edition)
researchProduct

Trefoil factor-3 and galectin-4 as new candidates for prognostic biomarkers in ST-segment elevation myocardial infarction

2020

medicine.medical_specialtybusiness.industryTrefoil factor 3Galectin 4Galectin 4Myocardial InfarctionElevationGeneral MedicinePrognosismedicine.diseaseElectrocardiographyTreatment OutcomeInternal medicineCardiologyHumansST Elevation Myocardial InfarctionMedicineST segmentMyocardial infarctionTrefoil Factor-3businessBiomarkersRevista Española de Cardiología (English Edition)
researchProduct

Iron deficiency and long-term mortality in elderly patients with acute coronary syndrome.

2018

Aim: We evaluated the relationship between iron deficiency (ID) and long-term mortality risk in elderly patients with acute coronary syndrome (ACS). Methods: In this prospective observational study, we included 252 patients older than 65 years with ACS. Transferrin saturation (TSAT) and ferritin were collected before discharge. Results: Mean age, hemoglobin and GRACE score were 78 ± 7 years, 12.4 ± 1.8 g/dl and 138.8 ± 25.3, respectively, 112(44.4%) patients were women, and 151(59.9%) presented ID. During the follow-up, 121 (48%) patients died. Mortality rates among TSAT quartiles were: 2.38, 1.60, 0.90 and 0.95 × 10 person-years for Q1TSAT to Q4TSAT, respectively (p < 0.001) and did no…

medicine.medical_specialtyAcute coronary syndromeClinical Biochemistry030204 cardiovascular system & hematologyGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoverymedicineHumans030212 general & internal medicineProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbiologyTransferrin saturationbusiness.industryMortality rateBiochemistry (medical)TransferrinIron deficiencyIron Deficienciesmedicine.diseaseFerritinSurvival RateQuartileFerritinsbiology.proteinObservational studyHemoglobinbusinessBiomarkers in medicine
researchProduct

Entrenamiento de la musculatura inspiratoria y la electroestimulación muscular funcional en el tratamiento de la insuficiencia cardiaca con función s…

2019

SEC 2017: Congreso de las Enfermedades Cardiovasculares Introducción y objetivos No se dispone de tratamientos farmacológicos que demuestren reducir la morbimortalidad asociada en pacientes con insuficiencia cardiaca y función sistólica conservada (IC-FEc). El objetivo del presente estudio fue evaluar si en pacientes con IC-FEc, el entrenamiento de la musculatura inspiratoria (EMI), la electroestimulación muscular funcional (EMF) o la combinación de ambas (EMI + EMF) puede mejorar la capacidad funcional, calidad de vida, parámetros de disfunción diastólica o biomarcadores a las 12 y 24 semanas. Métodos Un total de 61 pacientes estables con IC-FEc (clase funcional de la New York Heart Associ…

heart failure with preserved ejection fractioncapacidad funcionalbusiness.industry030204 cardiovascular system & hematologyinsuficiencia cardiaca con función sistólica conservadaexercise capacity03 medical and health sciences0302 clinical medicinequality of lifecalidad de vidaMedicinephysical therapyCardiology and Cardiovascular MedicinebusinessHumanitiesterapia físicaRevista Española de Cardiología
researchProduct

Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure.

2015

BACKGROUND Tricuspid regurgitation (TR) is a common echocardiographic finding that has been related to adverse outcome under various clinical scenarios. Nevertheless, evidence supporting its prognostic value in heart failure (HF) is scarce, and, in most cases, contradictory. We evaluated the association of TR grade with 1-year all-cause mortality in acute HF (AHF). METHODS AND RESULTS: We included 1,842 consecutive patients admitted for AHF. Mean age was 72.8±11.3 years, 51% were female and 45.5% had LVEF <50%. The severity of TR was graded in non-TR, mild (1), moderate (2), moderate-severe (3) and severe (4). At 1-year follow-up, 370 patients (20.1%) had died. In patients with LVEF ≥50%, a…

Malemedicine.medical_specialtySystolic functionRegurgitation (circulation)Ventricular Function LeftRisk FactorsInternal medicinemedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overHeart FailureEjection fractionbusiness.industryHazard ratioMean ageGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalTricuspid Valve InsufficiencyEchocardiographyHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesCirculation journal : official journal of the Japanese Circulation Society
researchProduct

Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponi…

2020

Background Undetectable high-sensitivity cardiac troponin (hs-cTn) in a single determination upon admission may rule out acute coronary syndrome. We investigated undetectable hs-cTnT (&amp;lt;detection limit; &amp;lt;5 ng/l) together with clinical risk scores (GRACE, TIMI, HEART and a previously published simple score), for one-year outcomes in patients with chest pain and normal hs-cTnT (&amp;lt;99th percentile; &amp;lt;14 ng/l) upon admission. Methods This study was a retrospective design involving 2254 consecutive patients (July 2016–November 2017). The primary endpoint was one-year death or acute myocardial infarction; the secondary endpoint added unstable angina requiring revasculariz…

MaleChest PainAcute coronary syndromemedicine.medical_specialtyCardiac troponinmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineChest painRevascularizationRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicinemedicineHumans030212 general & internal medicineRetrospective StudiesInpatientsbiologybusiness.industryUnstable anginaGeneral MedicineMiddle AgedPrognosismedicine.diseaseTroponinTroponinHigh sensitivity troponinRisk stratificationbiology.proteinCardiologyFemalemedicine.symptomEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Percutaneous coronary intervention and recurrent hospitalizations in elderly patients with non ST-segment acute coronary syndrome: The role of frailty

2017

MaleAcute coronary syndromemedicine.medical_specialtyTime FactorsFrail Elderlymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyPatient ReadmissionElectrocardiography03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineInternal medicinemedicineHumansST segmentProspective Studies030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryPercutaneous coronary interventionmedicine.diseaseTreatment OutcomeConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Growth differentiation factor 15 and geriatric conditions in acute coronary syndrome

2019

Abstract Background Growth differentiation factor 15 (GDF-15) is a marker of cell senescence. Age is a well-known determinant of GDF-15 levels, yet no study has analyzed the relationship between geriatric conditions and GDF-15. We hypothesize that geriatric conditions reflecting biological age might be stronger determinants of GDF-15 than chronological age in elderly patients with acute coronary syndrome. Methods A total of 208 patients (mean age = 78.3 ± 7.0 years) were included. Prior to discharge, a thorough geriatric assessment was performed and GDF-15 measured. Predictors of GDF-15 (transformed by its natural logarithm) were determined with linear regression. Furthermore, Cox regressio…

MaleAcute coronary syndromemedicine.medical_specialtyGrowth Differentiation Factor 15Multivariate analysisRenal function030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineAcute Coronary SyndromeGeriatric AssessmentAgedKillip classAged 80 and overProportional hazards modelbusiness.industryHazard ratiomedicine.diseaseComorbidityPatient DischargeConfidence intervalembryonic structuresFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Estrategias diuréticas en insuficiencia cardiaca aguda con disfunción renal: terapia convencional frente a guiada por el antígeno carbohidrato 125. D…

2017

Resumen Introduccion y objetivos El tratamiento optimo de pacientes con insuficiencia cardiaca aguda (ICA) y sindrome cardiorrenal tipo 1 (SCR-1) no esta bien definido. La hipoperfusion arterial y la congestion venosa tienen un papel fundamental en la fisiopatologia del SCR-1. El antigeno carbohidrato 125 (CA125) ha emergido como marcador indirecto de sobrecarga de volumen en la ICA. El objetivo de este estudio es evaluar la utilidad del CA125 para el ajuste del tratamiento diuretico de pacientes con SCR-1. Metodos Ensayo clinico multicentrico, abierto y paralelo, que incluye a pacientes con ICA y creatinina ≥ 1,4 mg/dl al ingreso, aleatorizados a: a)  estrategia convencional: titulacion ba…

03 medical and health sciences0302 clinical medicinebusiness.industryMedicine030212 general & internal medicine030204 cardiovascular system & hematologyCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction

2017

Functional mitral regurgitation (FMR) is a common finding in patients with acute heart failure (AHF) and reduced left ventricular ejection fraction (heart failure and reduced ejection fraction [HFrEF]). However, its clinical impact remains unclear. We aimed to evaluate the association between the severity of FMR after clinical stabilization and short-term adverse outcomes after a hospitalization for AHF. We prospectively included 938 consecutive patients with HFrEF discharged after a hospitalization for AHF, after excluding those with organic valve disease, congenital heart disease, or aortic valve disease. FMR was assessed semiquantitatively by color Doppler analysis of the regurgitant jet…

Malemedicine.medical_specialtyHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointHumansIn patientProspective Studies030212 general & internal medicineAdverse effectProspective cohort studyAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyStroke VolumePrognosismedicine.diseaseEchocardiography DopplerSurvival RateSpainHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Role of Neutrophil Gelatinase-associated Lipocalin in the Detection of Contrast-induced Nephropathy in Patients Undergoing a Coronary Angiography

2015

MaleCoronary angiographyAcute coronary syndromemedicine.medical_specialty030232 urology & nephrologyContrast-induced nephropathyContrast Media030204 cardiovascular system & hematologyLipocalinCoronary AngiographyRisk AssessmentSensitivity and Specificity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineText miningLipocalin-2Triiodobenzoic AcidsInternal medicineHumansMedicineAcute Coronary SyndromeAgedCreatininebusiness.industryAcute kidney injuryGeneral MedicineAcute Kidney InjuryMiddle Agedmedicine.diseaseTriiodobenzoic AcidsLogistic ModelschemistryCreatinineLinear ModelsCardiologyFemalebusinessRevista Española de Cardiología (English Edition)
researchProduct

Valor pronóstico a largo plazo del análisis completo de los índices de resonancia magnética cardiaca tras un infarto de miocardio con elevación del s…

2013

Resumen Introduccion y objetivos Se ha demostrado el valor pronostico de varios indices de resonancia magnetica cardiaca a medio plazo tras un infarto agudo de miocardio con elevacion del segmento ST. La extension de la necrosis transmural permite una prediccion simple y exacta de viabilidad miocardica. Sin embargo, se desconoce su valor pronostico a largo plazo mas alla de una completa evaluacion clinica y por resonancia. Nuestra hipotesis es que la evaluacion semicuantitativa de la extension de la necrosis transmural es el mejor indice de resonancia para predecir el pronostico a largo plazo tras un infarto con elevacion del segmento ST. Metodos Se realizo un estudio cuantitativo con reson…

Gynecologymedicine.medical_specialtybusiness.industrymedicineCardiology and Cardiovascular MedicinebusinessRevista Española de Cardiología
researchProduct

Clinical History and Detectable Troponin Concentrations below the 99th Percentile for Risk Stratification of Patients with Chest Pain and First Norma…

2021

Decision-making is challenging in patients with chest pain and normal high-sensitivity cardiac troponin T (hs-cTnT

medicine.medical_specialtyAcute coronary syndromechest painclinical evaluationmacromolecular substances030204 cardiovascular system & hematologyChest painArticleacute coronary syndrome03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpoint030212 general & internal medicineMyocardial infarctionbiologybusiness.industrytroponinHazard ratioRGeneral MedicineEmergency departmentmedicine.diseaseTroponinischemic heart diseaseConfidence intervalbiology.proteinCardiologyMedicinemedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Right ventricular function and iron deficiency in acute heart failure

2021

Abstract Aims Iron deficiency (ID) is a frequent finding in patients with chronic and acute heart failure (AHF) along the full spectrum of left ventricular ejection fraction (LVEF). Iron deficiency has been related to ventricular systolic dysfunction, but its role in right ventricular function has not been evaluated. We sought to evaluate whether ID identifies patients with greater right ventricular dysfunction in the setting of AHF. Methods and results We prospectively included 903 patients admitted with AHF. Right systolic function was evaluated by tricuspid annular plane systolic excursion (TAPSE) and the ratio TAPSE/pulmonary artery systolic pressure (TAPSE/PASP). Iron deficiency was de…

medicine.medical_specialtyVentricular Dysfunction Right030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineVentricular Function Left03 medical and health sciences0302 clinical medicineLeft ventricle ejection fraction[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInterquartile rangeInternal medicinemedicineHumans030212 general & internal medicineSystoleAgedAged 80 and overHeart FailureIron deficiency.Ejection fractionAnemia Iron-DeficiencybiologyTransferrin saturationbusiness.industryIron deficiencyRight ventricle ejection fractionStroke VolumeGeneral MedicineMiddle AgedPrognosismedicine.disease[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemTricuspid annular plane systolic excursionFerritinBlood pressureHeart failureVentricular Function Rightbiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusiness
researchProduct

Relation of Low Lymphocyte Count to Frailty and its Usefulness as a Prognostic Biomarker in Patients &gt;65 Years of Age With Acute Coronary Syndrome

2020

Low lymphocyte count, as a marker of inflammation and immunosuppression, may be useful for identifying frail patients. In this work, we aimed to evaluate the association between low-relative lymphocyte count (Lymph%) and frailty status in patients >65 years old with acute coronary syndromes (ACS), and whether Lymph% is associated with morbimortality beyond standard prognosticators and frailty. In this prospective observational study, we included 488 hospital survivors of an episode of an ACS >65 years old. Total and differential white blood cells and frailty status were assessed at discharge. Frailty was evaluated using the Fried score at discharge and defined as Fried≥3. The independent as…

Malemedicine.medical_specialtyAcute coronary syndromeMultivariate analysisLymphocytemedicine.medical_treatment030204 cardiovascular system & hematologyLogistic regression03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeInternal medicinemedicineHumansLymphocyte CountProspective Studies030212 general & internal medicineAcute Coronary SyndromeGeriatric AssessmentAgedFrailtyProportional hazards modelbusiness.industryImmunosuppressionPrognosismedicine.diseaseSurvival Ratemedicine.anatomical_structureSpainCardiologyFemaleLymphCardiology and Cardiovascular MedicinebusinessBiomarkersThe American Journal of Cardiology
researchProduct

Troponina T de alta sensibilidad y riesgo de hospitalizaciones recurrentes tras un ingreso por insuficiencia cardíaca aguda

2017

Resumen Objetivos La troponina de alta sensibilidad es un biomarcador de dano miocardico que se asocia a un mayor riesgo de mortalidad y progresion de la enfermedad en pacientes con insuficiencia cardiaca aguda (ICA). Sin embargo, su relacion con el riesgo de futuras rehospitalizaciones es menos conocido. El objetivo de este estudio fue evaluar la asociacion entre los valores de troponina T ultrasensible (TnT-us) en pacientes con ICA y el riesgo de hospitalizaciones recurrentes en el seguimiento. Metodos Se incluyo prospectivamente una cohorte de 621 pacientes consecutivos con ICA, excluyendose pacientes con sindrome coronario agudo. Se determino la TnT-us obtenida en el primer contacto med…

03 medical and health sciences0302 clinical medicinebusiness.industryMedicine030212 general & internal medicineGeneral Medicine030204 cardiovascular system & hematologybusinessHumanitiesRevista Clínica Española
researchProduct

P2516Low relative lymphocyte count as a marker of frailty in patients with acute coronary syndromes

2017

medicine.medical_specialtymedicine.anatomical_structurebusiness.industryLymphocyteInternal medicinemedicineIn patientCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Long-term outcome of patients with NSTEMI and nonobstructive coronary arteries by different angiographic subtypes

2021

Discordant data have been reported on the prognosis of myocardial infarction with nonobstructive coronary arteries (MINOCA). Moreover, few data are available on the impact of angiographic subtypes. The objectives of this study were to assess the prognostic impact on the long-term follow-up of the diagnosis of MINOCA and its angiographic subtypes.We included 591 consecutive patients with non-ST-segment elevation myocardial infarction (NSTEMI) who underwent coronary angiography. MINOCA was classified according to angiographic findings as smooth coronary arteries, mild irregularities (30% stenosis), and moderate atherosclerosis (30%-49% stenosis). The primary endpoint was a composite of mortal…

Coronary angiographymedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematologyCoronary AngiographyRevascularization03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansMyocardial infarctionNon-ST Elevated Myocardial Infarctionbusiness.industryGeneral Medicinemedicine.diseaseCoronary VesselsIndependent factorCoronary arteriesmedicine.anatomical_structureCardiologyST Elevation Myocardial InfarctionbusinessMaceRevista Española de Cardiología (English Edition)
researchProduct

Homocysteine and long-term recurrent infarction following an acute coronary syndrome.

2021

En Cardiology Journal. Gdańsk (Polonia) : Via Medica. Vol. 28, n. 4 (01 jul. 2021), pp. 598-606. ISSN 1897-5593. e-ISSN 1898-018X. Este artículo se encuentra disponible en la siguiente URL: https://journals.viamedica.pl/cardiology_journal/article/view/CJ.a2020.0170/52602 En este artículo de investigación también participan: Maria Marco, Teresa García-Ballester, Begoña Zorio, Eduardo Núñez, Francisco J. Chorro, Juan Sanchis y Julio Núñez. Background: There are no well-established predictors of recurrent ischemic coronary events after an acute coronary syndrome (ACS). Higher levels of homocysteine have been reported to be associated with an increased atherosclerotic burden. The primary endpoi…

Malemedicine.medical_specialtyAcute coronary syndromeHomocysteinemedicine.medical_treatmentCoronary heart disease - Risk factors.Infarto de miocardio - Factores de riesgo.Enfermedad coronaria - Factores de riesgo.InfarctionClinical CardiologyRevascularizationCoronary artery diseasechemistry.chemical_compoundInterquartile rangeRisk FactorsInternal medicineMyocardial infarction - Risk factors.medicineHumansMyocardial infarctionAcute Coronary SyndromeHomocysteineAgedacute coronary syndrome coronary artery disease homocysteine recurrent myocardial infarction risk factorsCardiovascular system - Diseases - Risk factors.Framingham Risk Scorebusiness.industryEnfermedades cardiovasculares - Factores de riesgo.General Medicinemedicine.diseaseHospitalizationchemistryCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiology journal
researchProduct

CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

2020

BACKGROUND: The optimal diuretic treatment strategy for patients with acute heart failure and renal dysfunction remains unclear. Plasma carbohydrate antigen 125 (CA125) is a surrogate of fluid overload and a potentially valuable tool for guiding decongestion therapy. The aim of this study was to determine if a CA125-guided diuretic strategy is superior to usual care in terms of short-term renal function in patients with acute heart failure and renal dysfunction at presentation. METHODS: This multicenter, open-label study randomized 160 patients with acute heart failure and renal dysfunction into 2 groups (1:1). Loop diuretics doses were established according to CA125 levels in the CA125-gui…

Maleendocrine system diseasesPREDICTIONmedicine.medical_treatmentUrine030204 cardiovascular system & hematologyKidney Function TestsCONGESTIONBiomarker guided-therapy0302 clinical medicineSodium Potassium Chloride Symporter InhibitorsFurosemideNatriuretic peptideMedicineRenal Insufficiency030212 general & internal medicinePrecision MedicineANTIGEN CARBOHYDRATE 125Aged 80 and overFurosemideGeneral MedicineDiuretic treatmentEUROPEAN-SOCIETYClinical trialFemaleTRIALmedicine.drugmedicine.medical_specialtyRenal failureSTRATEGIESmedicine.drug_classUrologyRenal function03 medical and health sciencesHumansIn patientAgedHeart FailureSERUM CREATININENATRIURETIC PEPTIDEbusiness.industryMORTALITYMembrane ProteinsAcute heart failuremedicine.diseaseClinical trialCarbohydrate antigen 125CA-125 AntigenHeart failureDiuretic treatmentDiureticbusinessCARDIORENAL SYNDROME
researchProduct

Length of stay and risk of very early readmission in acute heart failure

2016

In patients admitted for acute heart failure (AHF), optimal length of stay (LOS) remains controversial. Longer hospitalizations are associated with worse prognosis, but little is known about short hospitalizations. The aim of this work was to evaluate the relationship between LOS and the risk of short-term readmission in patients discharged after a hospitalization for AHF.We included 2110 consecutive patients. The independent associations between LOS and unplanned 10, 15 and 30-day readmissions were evaluated by Cox regression analysis adjusted for competing events. LOS was categorized as LOS1: ≤4days, LOS2: 5-7days, LOS3: 8-10days, and LOS4:10days.The mean age was 73±11years and 52.6% exhi…

Malemedicine.medical_specialtyTime FactorsMultivariate analysis030204 cardiovascular system & hematologyPatient ReadmissionVentricular Function Left03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineInternal MedicinemedicineHumansIn patientProspective Studies030212 general & internal medicineAgedProportional Hazards ModelsAged 80 and overHeart FailureAmino-terminal pro-brain natriuretic peptideEjection fractionbusiness.industryProportional hazards modelMean ageLength of StayMiddle Agedmedicine.diseasemedicine.anatomical_structureSpainVentricleHeart failureAcute DiseaseMultivariate AnalysisCardiologyFemalebusinessEuropean Journal of Internal Medicine
researchProduct

Frailty Scales for Prognosis Assessment of Older Adult Patients after Acute Myocardial Infarction

2021

We aimed to compare the prognostic value of two different measures, the Fried’s Frailty Scale (FFS) and the Clinical Frailty Scale (CFS), following myocardial infarction (MI). We included 150 patients ≥ 70 years admitted from AMI. Frailty was evaluated on the day before discharge. The primary endpoint was number of days alive and out of hospital (DAOH) during the first 800 days. Secondary endpoints were mortality and a composite of mortality and reinfarction. Frailty was diagnosed in 58% and 34% of patients using the FFS and CFS scales, respectively. During the first 800 days 34 deaths and 137 admissions occurred. The number of DAOH decreased significantly with increasing scores of both FFS…

Out of hospitalmedicine.medical_specialtyMultivariate analysisAdult patientsbusiness.industryRacute myocardial infarctionGeneral Medicinefrailtymedicine.diseaseArticleFried’s frailty scoreInternal medicinemedicineClinical endpointClinical Frailty ScaleMedicineMyocardial infarctionMortality predictionbusinessfrailty; acute myocardial infarction; Fried’s frailty score; Clinical Frailty Scalehealth care economics and organizationsJournal of Clinical Medicine
researchProduct

Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome.

2019

Background The Charlson's is the most used comorbidity index. It comprises 19 comorbidities, some of which are infrequent in elderly patients with acute coronary syndrome (ACS), while some others are manifestations of cardiac disease rather than comorbidities. Our goal was to simplify comorbidity assessment in elderly non-ST-segment elevation ACS patients. Methods The study group consisted of 1 training (n = 920, 76 ± 7 years) and 1 testing (n = 532; 84 ± 4 years) cohorts. The end-point was all-cause mortality at 1-year follow-up. Comorbidities were assessed selecting those medical disorders other than cardiac disease that were independently associated with mortality by multivariable analys…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsAnemiaEnfermedad cardiovascularAncianoCharlson indexDiseaseComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusCause of Deathmental disordersInternal MedicinemedicineHumans030212 general & internal medicineHospital MortalityProspective StudiesAcute Coronary SyndromeAgedProportional Hazards ModelsAged 80 and overbusiness.industrymedicine.diseaseComorbiditySpainRisk stratificationCohortCardiopatía coronariaFemalebusinessAncianosEuropean journal of internal medicine
researchProduct

Factor trefoil-3 y galectina-4 como nuevos candidatos para biomarcadores pronósticos en infarto de miocardio con elevación del segmento ST

2020

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Clinical Evaluation Versus Undetectable High-Sensitivity Troponin for Assessment of Patients With Acute Chest Pain.

2016

Decision-making in acute chest pain remains challenging despite normal (below ninety-ninth percentile) high-sensitivity troponin (hs-cTn). Some studies suggest that undetectable hs-cTn, far below the ninety-ninth percentile, might rule out acute coronary syndrome. We investigated clinical data in comparison to undetectable hs-cTnT. The study comprised 682 patients (November 2010 to September 2011) presenting at the emergency department with chest pain and normal hs-cTnT (14 ng/l). The main end point was major adverse cardiac events (MACE: death, myocardial infarction, readmission for unstable angina, or revascularization) at a 4-year median follow-up; secondary end point was 30-day MACE. A …

MalePercentileAcute coronary syndromemedicine.medical_specialtyChest PainClinical Decision-Making030204 cardiovascular system & hematologyChest painSeverity of Illness IndexDiagnosis Differential03 medical and health sciencesElectrocardiography0302 clinical medicineTroponin TInternal medicineSeverity of illnessMedicineHumans030212 general & internal medicineProspective StudiesProspective cohort studyhealth care economics and organizationsbiologymedicine.diagnostic_testbusiness.industryIncidenceEmergency departmentMiddle Agedmedicine.diseasePrognosisTroponinAcute PainSpainbiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalElectrocardiographyBiomarkersFollow-Up StudiesThe American journal of cardiology
researchProduct

Carga de hospitalizaciones recurrentes tras una hospitalización por insuficiencia cardiaca aguda: insuficiencia cardiaca con función sistólica conser…

2017

Introduction and objectives: Heart failure with preserved ejection fraction and reduced ejection fraction share a high mortality risk. However, differences in the rehospitalization burden over time between these 2 entities remains unclear. Methods: We prospectively included 2013 consecutive patients discharged for acute heart failure. Of these, 1082 (53.7%) had heart failure with preserved ejection fraction and 931 (46.2%) had heart failure with reduced ejection fraction. Cox and negative binomial regression methods were used to evaluate the risks of death and repeat hospitalizations, respectively. Results: At a median follow-up of 2.36 years (interquartile range: 0.96-4.65), 1018 patients …

HospitalizationsGynecologymedicine.medical_specialtybusiness.industryPronósticoHeart failure030204 cardiovascular system & hematologyPrognosis03 medical and health sciences0302 clinical medicineHospitalizacionesmedicine030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessInsuficiencia cardiacaRevista Española de Cardiología
researchProduct

Pronóstico a largo plazo de pacientes con IAMSEST y coronarias sin lesiones obstructivas según los distintos subtipos angiográficos

2021

Resumen Introduccion y objetivos Hay evidencia discordante sobre el pronostico del infarto sin lesiones coronarias obstructivas (MINOCA). Ademas, existen pocos datos del impacto de sus subtipos angiograficos. Los objetivos del estudio son evaluar el impacto pronostico del MINOCA y sus subtipos angiograficos en el seguimiento a largo plazo. Metodos Se incluyo a 591 pacientes consecutivos con IAMSEST a los que se realizo una coronariografia. Los pacientes con MINOCA se clasificaron segun la angiografia en: coronarias lisas, irregularidades leves (estenosis  Resultados En total, 121 pacientes (20,5%) no tenian lesiones obstructivas. El MINOCA se asocio con una menor ocurrencia de MACE (p = 0,0…

03 medical and health sciences0302 clinical medicinebusiness.industryMedicine030204 cardiovascular system & hematologyCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Long-Term Prognostic Value of Cognitive Impairment on Top of Frailty in Older Adults after Acute Coronary Syndrome

2021

Frailty is a marker of poor prognosis in older adults after acute coronary syndrome. We investigated whether cognitive impairment provides additional prognostic information. The study population consisted of a prospective cohort of 342 older (&gt

medicine.medical_specialtyAcute coronary syndromebusiness.industrylcsh:Rlcsh:MedicineCognitionGeneral Medicinefrailty030204 cardiovascular system & hematologymedicine.diseaseArticleacute coronary syndrome03 medical and health sciences0302 clinical medicineInternal medicinemedicinePopulation studyDementia030212 general & internal medicineMyocardial infarctionbusinessCognitive impairmentProspective cohort studySubclinical infectioncognitive impairmentJournal of Clinical Medicine
researchProduct

Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

2018

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to quantify cardiac magnetic resonance changes in myocardial iron content after administration of intravenous FCM in patients with heart failure and iron deficiency and contrast them with parameters of heart failure severity. This is a multicenter, double-blind, randomized study. Fifty patients with stable symptomatic heart failure, left ventricular ejection fraction <50%, and iron deficiency will be r…

MaleTime FactorsMyocardial ironheart failure030204 cardiovascular system & hematologyFerric CompoundsSeverity of Illness IndexVentricular Function Left030218 nuclear medicine & medical imaginglaw.invention0302 clinical medicineiron deficiencyClinical ProtocolsQuality of lifeRandomized controlled triallawCardiac Magnetic Resonance Ferric Carboxymaltose Heart Failure Iron Deficiency Myocardial IronInfusions IntravenousEjection fractionAnemia Iron-DeficiencyGeneral MedicineIron deficiencyferric carboxymaltoseTreatment OutcomeResearch DesignCardiologyFemaleCardiology and Cardiovascular MedicineCardiac function curvemedicine.medical_specialtyTrial DesignsMagnetic Resonance Imaging CinePlacebocardiac magnetic resonance03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansMaltosemyocardial ironAgedHeart Failurebusiness.industryMyocardiumStroke VolumeRecovery of Functionmedicine.diseaseSpainHeart failureHematinicsQuality of Lifebusiness
researchProduct